These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 9822546

  • 21. Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.
    Colucci MA, Reigan P, Siegel D, Chilloux A, Ross D, Moody CJ.
    J Med Chem; 2007 Nov 15; 50(23):5780-9. PubMed ID: 17944451
    [Abstract] [Full Text] [Related]

  • 22. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
    Han Y, Shen H, Carr BI, Wipf P, Lazo JS, Pan SS.
    J Pharmacol Exp Ther; 2004 Apr 15; 309(1):64-70. PubMed ID: 14718602
    [Abstract] [Full Text] [Related]

  • 23. Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies.
    Hassani M, Cai W, Koelsch KH, Holley DC, Rose AS, Olang F, Lineswala JP, Holloway WG, Gerdes JM, Behforouz M, Beall HD.
    J Med Chem; 2008 Jun 12; 51(11):3104-15. PubMed ID: 18457384
    [Abstract] [Full Text] [Related]

  • 24. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
    Kadela-Tomanek M, Bębenek E, Chrobak E, Marciniec K, Latocha M, Kuśmierz D, Jastrzębska M, Boryczka S.
    Eur J Med Chem; 2019 Sep 01; 177():302-315. PubMed ID: 31158746
    [Abstract] [Full Text] [Related]

  • 25. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
    Beall HD, Mulcahy RT, Siegel D, Traver RD, Gibson NW, Ross D.
    Cancer Res; 1994 Jun 15; 54(12):3196-201. PubMed ID: 8205540
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Studies on quinones. Part 45: novel 7-aminoisoquinoline-5,8-quinone derivatives with antitumor properties on cancer cell lines.
    Valderrama JA, Ibacache JA, Arancibia V, Rodriguez J, Theoduloz C.
    Bioorg Med Chem; 2009 Apr 01; 17(7):2894-901. PubMed ID: 19269832
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Studies of pyrrolo[1,2-alpha]benzimidazolequinone DT-diaphorase substrate activity, topoisomerase II inhibition activity, and DNA reductive alkylation.
    Skibo EB, Gordon S, Bess L, Boruah R, Heileman MJ.
    J Med Chem; 1997 Apr 25; 40(9):1327-39. PubMed ID: 9135030
    [Abstract] [Full Text] [Related]

  • 32. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
    Xu S, Yao H, Pei L, Hu M, Li D, Qiu Y, Wang G, Wu L, Yao H, Zhu Z, Xu J.
    Eur J Med Chem; 2017 May 26; 132():310-321. PubMed ID: 28395199
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cross-linking and sequence-specific alkylation of DNA by aziridinylquinones. 3. Effects of alkyl substituents.
    Hargreaves RH, O'Hare CC, Hartley JA, Ross D, Butler J.
    J Med Chem; 1999 Jun 17; 42(12):2245-50. PubMed ID: 10377230
    [Abstract] [Full Text] [Related]

  • 35. Mitomycin C.
    Gibson NW, Ross D.
    Cancer Chemother Biol Response Modif; 1993 Jun 17; 14():45-54. PubMed ID: 8312113
    [Abstract] [Full Text] [Related]

  • 36. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
    Marx KA, O'Neil P, Hoffman P, Ujwal ML.
    J Chem Inf Comput Sci; 2003 Jun 17; 43(5):1652-67. PubMed ID: 14502500
    [Abstract] [Full Text] [Related]

  • 37. Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.
    Ross D, Beall H, Traver RD, Siegel D, Phillips RM, Gibson NW.
    Oncol Res; 1994 Jun 17; 6(10-11):493-500. PubMed ID: 7620217
    [Abstract] [Full Text] [Related]

  • 38. Kinetics of NAD(P)H:quinone oxidoreductase I (NQO1) inhibition by mitomycin C in vitro and in vivo.
    Gustafson DL, Siegel D, Rastatter JC, Merz AL, Parpal JC, Kepa JK, Ross D, Long ME.
    J Pharmacol Exp Ther; 2003 Jun 17; 305(3):1079-86. PubMed ID: 12649308
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.